Glycohemoglobin in postpartum women

Area of Science:

• Reproductive Endocrinology
• Maternal-Fetal Medicine
• Clinical Biochemistry

Background:

• Women delivering large for gestational age (LGA) infants face increased risks of glucose intolerance during pregnancy.
• Postpartum assessment of glucose metabolism is crucial for identifying mothers at risk.
• Established reference ranges for postpartum glucose markers are essential for comparison.

Purpose of the Study:

• To investigate postpartum glucose intolerance markers (fasting plasma glucose and glycohemoglobin) in mothers of LGA infants.
• To compare these markers with those of mothers delivering appropriate for gestational age (AGA) infants and controls.
• To explore correlations between maternal glucose markers, infant birth weight, and maternal anthropometric data.

Main Methods:

• Study included 146 mothers of LGA infants, mothers of AGA infants, and control mothers without diabetic risk factors.
• Fasting plasma glucose (FPG) and glycohemoglobin (HbA1c) levels were measured in the early postpartum period (<10 days).
• Infant birth weights, perinatal histories, and maternal anthropometric data were collected; linear regression analysis was performed.

Main Results:

• Mothers of LGA infants exhibited elevated mean HbA1c and FPG levels compared to control groups.
• Significant correlations were found between maternal HbA1c, FPG, and infant birth weight corrected for gestational age (P < .001).
• LGA infants showed increased perinatal morbidity (P < .05) compared to combined control groups.

Conclusions:

• Elevated postpartum FPG and HbA1c levels are associated with delivering LGA infants.
• Maternal glucose markers and infant birth weight are significantly interrelated, suggesting a link between maternal metabolic status and fetal growth.
• Postpartum monitoring of glucose metabolism is recommended for mothers of LGA infants due to potential underlying glucose intolerance and increased perinatal risks.